Cargando…
Angiotensin II receptor blockers and cardiovascular protection: Focus on left ventricular hypertrophy regression and atrial fibrillation prevention
Left ventricular hypertrophy (LVH) and atrial fibrillation (AF) are strong predictors of cardiovascular (CV) morbidity and mortality, independently of blood pressure levels and other modifiable and nonmodifiable risk factors. The actions of circulating and tissue angiotensin II, mediated by AT1 rece...
Autores principales: | Cuspidi, Cesare, Negri, Francesca, Zanchetti, Alberto |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464755/ https://www.ncbi.nlm.nih.gov/pubmed/18629360 |
Ejemplares similares
-
Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials
por: Cuspidi, Cesare, et al.
Publicado: (2009) -
Left ventricular hypertrophy in hypertension: Need of ethnic‐specific criteria
por: Cuspidi, Cesare, et al.
Publicado: (2022) -
Left ventricular hypertrophy in hypertension: Is the electrocardiogram enough for risk stratification?
por: Cuspidi, Cesare, et al.
Publicado: (2022) -
Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy
por: Salama, Guy
Publicado: (2022) -
When sweet becomes too sweet: Left ventricular longitudinal strain in focus
por: Tadic, Marijana, et al.
Publicado: (2018)